Reduced expression of inflammasome complex components in cluster headache

Area of Science:

• Neuroscience
• Immunology
• Pathophysiology

Background:

• Inflammation is suspected in cluster headache (CH) pathophysiology, with a potential role for interleukin-1β (IL-1β).
• Investigating IL-1β-inducing systems, inflammasome complex, and NF-κB signaling as potential biomarkers in CH is crucial.

Purpose of the Study:

• To measure peripheral blood expression levels of IL-1β-inducing systems, inflammasome complex, and NF-κB signaling in CH patients.
• To evaluate these factors as potential biomarkers for CH.

Main Methods:

• Collected blood mononuclear cells (PBMCs) and sera from episodic migraine patients, chronic CH patients, and healthy individuals.
• Measured levels of inflammasome components (NLRP1, NLRP3, caspase 1, ASC), IL-1β, IL-18, nitric oxide synthase isoforms, neuron-specific enolase, NF-κB, HMGB1, S100b, and IL-4 using qPCR and ELISA.

Main Results:

• NLRP3 expression was reduced in CH patients' PBMCs during attacks and headache-free periods.
• CH attack patients showed higher IL-1β and NF-κB expression in PBMCs, but differences were not statistically significant.
• Lower levels of NLRP1, HMGB1, S100b, NSE, nNOS, and eNOS were observed in patients with multiple autonomic manifestations.

Conclusions:

• Results suggest the involvement of the IL-1β system in CH attacks.
• Inflammasome complex components in peripheral blood do not appear to play a role in CH pathophysiology.
• The inflammasome complex is unlikely to serve as a biomarker for CH.